Zhitong Financial APP News, Jieqiang equipment (300875.SZ) issued a pre-plan for the company to issue shares and pay cash to buy assets and raise matching funds and related party transactions. The listed company plans to issue shares to Wang Qiguang, Wu Zhaoguang, Wang Jing, Qian Longgang, Chang Junlin, Zhang Jing, Xiang Hao, Zhang Chunlei, Sheng Zengli, Chen Feng and pay cash to buy 100% equity interest in Cadino Technology. Among them, the payment ratio of shares and cash will be clearly agreed upon by the parties to the transaction after the signing of a supplementary agreement.
In addition, in this transaction, listed companies plan to issue shares to no more than 35 qualified specific targets to raise matching funds. The total amount of supporting funds raised shall not exceed 100% of the transaction price of the assets to be purchased by issuing shares, and the number of shares issued shall not exceed 30% of the total share capital of the listed company before this issue.
The share issue price of this issue and cash purchase of assets is 24.46 yuan per share. The issue price of the shares issued by raising matching funds shall not be less than 80% of the average price of the company's shares in the 20 trading days before the first day of the issuance period. the matching funds raised are intended to be used to pay cash consideration, to pay transaction taxes and intermediary fees, to supplement the liquidity of listed companies and to repay bank loans.
The announcement shows that the main business of Cardino Technology, the target company to be purchased, is nuclear radiation detection and monitoring equipment, as well as technical research, design, development, production and sales of nuclear radiation protection, with downstream customers covering the military, nuclear industry, environmental protection, medical and health, customs and commodity inspection, homeland security, scientific research institutions, industry and mining, and many other fields.
After the completion of this transaction, on the one hand, the listed company and the target company will effectively coordinate research and development and innovation through research and development, patents, products, market and management, continuously improve the industrial layout and expand the portfolio of superior products, and achieve complementary advantages so as to further enhance the comprehensive strength and market share. On the other hand, listed companies can enhance the core competitiveness of nuclear and biochemical safety reconnaissance equipment and enhance their anti-risk ability by integrating product lines and R & D capabilities such as nuclear radiation detection and monitoring equipment and nuclear radiation protection. Return shareholders with better performance and profitability.
Upon application, the company's shares will resume trading on the morning of Wednesday, February 8, 2023.